On target dosing: erythropoietin exposure in neonates with hypoxic-ischemic encephalopathy in the HEAL trial.

2024
https://researcherprofiles.org/profile/562435688
39523391
Frymoyer A, Vasconcelos AG, Juul SE, Comstock BA, Heagerty PJ, Wu YW